Buy Rupatadine 10mg tablets Online in the UK
Rupatadine 10mg tablets are prescription-strength antihistamines for allergies, rashes and skin irritation and used for the treatment of allergic rhinitis (irritation of the nose, nasal passages etc) caused by allergens such as pollen or other substances eg house dust mites. Also recommended for eczema and psoriasis to reduce irritation and urge to scratch the affected areas.
Rupatadine is a member of the second-generation antihistamines drug class, more specifically, the histamine receptor antagonists drug class. It functions by preventing the effect of histamine, one of the body's natural substances. Many of the symptoms brought on by allergies are caused by histamine.
Each tablet contains: 10 mg of rupatadine (as fumarate) and is taken once daily without food.
This medication is available using our free online doctor service.
Rupatadine 10mg tablets 30 antihistamine reviews
How to use Rupatadine 10mg tablets 30 antihistamine
Adults over the age of 18: take ONE tablet DAILY.
If you are taking statin medication eg simvastatin or some immuno-suppressive medication eg tacrolimus then please speak to your pharmacist before taking this medication.
Side effects of Rupatadine 10mg tablets 30 antihistamine
Keep the blister in the outer carton in order to protect from light.
Not to be taken if you are hypersensitivity to the active substance or any of the excipients listed in the Ingredients section
Do not take with grapefruit juice
Rupatadine 10 mg Tablets should be used with caution in elderly patients (65 years and older). Although no overall differences in effectiveness or safety were observed in clinical trials, higher sensitivity of some older individuals cannot be excluded due to the low number of elderly patients enrolled
Cardiac safety of rupatadine was assessed in a Thorough QT/QTc study. Rupatadine up to 10 times therapeutic dose did not produce any effect on the ECG and hence raises no cardiac safety concerns. However, rupatadine should be used with caution in patients with known prolongation of the QT interval, patients with uncorrected hypokalemia, patients with ongoing proarrhythmic conditions, such as clinically significant bradycardia, acute myocardial ischemia.
Rupatadine 10 mg tablets has been administered to over 2043 adult and adolescent patients in clinical studies, 120 of whom received rupatadine for at least 1 year.
The most common adverse reactions in controlled clinical studies were somnolence (9.4%), headache (6.9%),fatigue (3.1%), asthenia (1.5%), dry mouth (1.2%) and dizziness (1.03%).
The majority of the adverse reactions observed in clinical trials were mild to moderate in severity and they usually did not require cessation of therapy.